Henan Newland Pharmaceutical Co. Ltd. A (301277) — Cash Flow Reinvestment Rate
Henan Newland Pharmaceutical Co. Ltd. A (301277) has a Cash Flow Reinvestment Rate of 0.99x as of December 2025, reinvesting CN¥115.33 Million (capex CN¥101.38 Million plus investments CN¥-13.95 Million) from operating cash flow of CN¥116.94 Million. See 301277 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Henan Newland Pharmaceutical Co. Ltd. A Cash Flow Reinvestment Rate (2020–2025)
Historical reinvestment intensity for Henan Newland Pharmaceutical Co. Ltd. A across 6 annual periods. For the full cash flow conversion analysis, see Henan Newland Pharmaceutical Co. Ltd. A cash conversion from operations.
Annual Cash Flow Reinvestment Rate for Henan Newland Pharmaceutical Co. Ltd. A (2020–2025)
Year-by-year capital reinvestment analysis for Henan Newland Pharmaceutical Co. Ltd. A. See Henan Newland Pharmaceutical Co. Ltd. A (301277) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.99x | CN¥115.33 Million | CN¥116.94 Million | CN¥101.38 Million | ▼ -33.9% |
| 2024 | 1.49x | CN¥189.07 Million | CN¥126.76 Million | CN¥110.79 Million | ▲ +71.3% |
| 2023 | 0.87x | CN¥225.97 Million | CN¥259.46 Million | CN¥96.51 Million | ▼ -90.6% |
| 2022 | 9.24x | CN¥765.51 Million | CN¥82.85 Million | CN¥74.34 Million | ▲ +1238.0% |
| 2021 | 0.69x | CN¥33.89 Million | CN¥49.08 Million | CN¥25.40 Million | ▼ -2.2% |
| 2020 | 0.71x | CN¥33.80 Million | CN¥47.86 Million | CN¥16.96 Million | — |